Literature DB >> 3622668

Chronic cough as a risk indicator of broncho-pulmonary disease.

H Puolijoki, A Lahdensuo.   

Abstract

The aim of this study was to discover the subsequent histories and ultimate diagnoses in 182 patients studied in a chest clinic because of unexplained cough. Twenty-nine patients (16%) developed asthma during the mean follow-up time of 4.4 years. Chronic bronchitis was diagnosed in 18 patients (10%) and sporadic instances of some other diseases were also seen. The development of asthma was studied both by calculating simple relative risks and using a multiple logistic model. Circadian changes in peak expiratory flow (PEF)-values and total blood eosinophil count were found to be the best variables for predicting the risk of developing asthma in a patient with unexplained cough, whereas mild bronchial hyperreactivity had only a low predictive value. If the risk of developing asthma in a patient presenting with unexplained cough is to be estimated, attention should be paid simultaneously to a number of variables. Even mild abnormalities in several variables can be significant when they occur together.

Entities:  

Mesh:

Year:  1987        PMID: 3622668

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  4 in total

Review 1.  Eosinophilic bronchitis: clinical manifestations and implications for treatment.

Authors:  P G Gibson; M Fujimura; A Niimi
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

2.  Prolonged exposure to damp and moldy workplaces and new-onset asthma.

Authors:  Kirsi Karvala; Elina Toskala; Ritva Luukkonen; Jukka Uitti; Sanna Lappalainen; Henrik Nordman
Journal:  Int Arch Occup Environ Health       Date:  2011-07-19       Impact factor: 3.015

3.  Persistent cough: is it asthma?

Authors:  A O Faniran; J K Peat; A J Woolcock
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

4.  Later development of asthma in patients with a negative methacholine inhalation challenge examined for suspected asthma.

Authors:  H Puolijoki; O Impivaara; K Liippo; E Tala
Journal:  Lung       Date:  1992       Impact factor: 2.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.